27572961|t|Transient Mild Cerebral Ischemia Significantly Deteriorated Cognitive Impairment in a Mouse Model of Alzheimer's Disease via Angiotensin AT1 Receptor.
27572961|a|BACKGROUND: Ischemic stroke is suggested to be potentially associated with cognitive impairment in Alzheimer's disease (AD). We hypothesized that cerebral ischemia deteriorates cognitive impairment in AD, through angiotensin II. METHODS: We used 5XFAD mouse, a model of AD with vascular and cerebral amyloid-beta deposition. Transient cerebral ischemia of mice was induced by bilateral common carotid artery occlusion (BCCAO) for 17 minutes. The posttreatment with olmesartan, an ARB, or vehicle was started at 24 hours after BCCAO and was performed for 5 weeks. Experimental mice consisted of 5 groups: (i) wild-type mice, (ii) wild-type mice with BCCAO, (iii) 5XFAD mice, (iv) 5XFAD mice with BCCAO, (v) 5XFAD mice with BCCAO and olmesartan postadministration. RESULTS: BCCAO in 5XFAD caused greater escape latency (P < 0.01) on water maze test than that in wild type, indicating that transient brief cerebral ischemia enhanced cognitive decline in 5XFAD mice. Posttreatment with olmesartan significantly reduced escape latency (P < 0.01) on water maze test, retention trial latency (P < 0.05) on passive avoidance test, and retention time of outer zone (P < 0.01) on open-field test in 5XFAD subjected to BCCAO. This protective effect of olmesartan against cognitive impairment in 5XFAD with BCCAO was associated with the protection of neuron and attenuation of oxidative stress in hippocampus and the suppression of blood-brain barrier disruption. CONCLUSIONS: We obtained the evidence that transient brief cerebral ischemia deteriorated cognitive impairment in AD model through AT1 receptor.
27572961	15	32	Cerebral Ischemia	Disease	MESH:D002545
27572961	47	59	Deteriorated	Disease	MESH:D000075902
27572961	60	80	Cognitive Impairment	Disease	MESH:D003072
27572961	86	91	Mouse	Species	10090
27572961	101	120	Alzheimer's Disease	Disease	MESH:D000544
27572961	163	178	Ischemic stroke	Disease	MESH:D002544
27572961	226	246	cognitive impairment	Disease	MESH:D003072
27572961	250	269	Alzheimer's disease	Disease	MESH:D000544
27572961	271	273	AD	Disease	MESH:D000544
27572961	297	314	cerebral ischemia	Disease	MESH:D002545
27572961	328	348	cognitive impairment	Disease	MESH:D003072
27572961	352	354	AD	Disease	MESH:D000544
27572961	397	402	5XFAD	CellLine	CVCL:5U93
27572961	403	408	mouse	Species	10090
27572961	421	423	AD	Disease	MESH:D000544
27572961	429	437	vascular	Disease	MESH:D057772
27572961	442	474	cerebral amyloid-beta deposition	Disease	MESH:D058225
27572961	486	503	cerebral ischemia	Disease	MESH:D002545
27572961	507	511	mice	Species	10090
27572961	537	568	common carotid artery occlusion	Disease	MESH:D002340
27572961	570	575	BCCAO	Disease	MESH:D002340
27572961	616	626	olmesartan	Chemical	MESH:C437965
27572961	677	682	BCCAO	Disease	MESH:D002340
27572961	727	731	mice	Species	10090
27572961	769	773	mice	Species	10090
27572961	790	794	mice	Species	10090
27572961	800	805	BCCAO	Disease	MESH:D002340
27572961	813	818	5XFAD	CellLine	CVCL:5U93
27572961	819	823	mice	Species	10090
27572961	830	835	5XFAD	CellLine	CVCL:5U93
27572961	836	840	mice	Species	10090
27572961	846	851	BCCAO	Disease	MESH:D002340
27572961	857	862	5XFAD	CellLine	CVCL:5U93
27572961	863	867	mice	Species	10090
27572961	873	878	BCCAO	Disease	MESH:D002340
27572961	883	893	olmesartan	Chemical	MESH:C437965
27572961	923	928	BCCAO	Disease	MESH:D002340
27572961	932	937	5XFAD	CellLine	CVCL:5U93
27572961	1054	1071	cerebral ischemia	Disease	MESH:D002545
27572961	1081	1098	cognitive decline	Disease	MESH:D003072
27572961	1102	1107	5XFAD	CellLine	CVCL:5U93
27572961	1108	1112	mice	Species	10090
27572961	1133	1143	olmesartan	Chemical	MESH:C437965
27572961	1340	1345	5XFAD	CellLine	CVCL:5U93
27572961	1359	1364	BCCAO	Disease	MESH:D002340
27572961	1392	1402	olmesartan	Chemical	MESH:C437965
27572961	1411	1431	cognitive impairment	Disease	MESH:D003072
27572961	1435	1440	5XFAD	CellLine	CVCL:5U93
27572961	1446	1451	BCCAO	Disease	MESH:D002340
27572961	1662	1679	cerebral ischemia	Disease	MESH:D002545
27572961	1680	1692	deteriorated	Disease	MESH:D000075902
27572961	1693	1713	cognitive impairment	Disease	MESH:D003072
27572961	1717	1719	AD	Disease	MESH:D000544
27572961	Negative_Correlation	MESH:C437965	MESH:D003072
27572961	Negative_Correlation	MESH:C437965	MESH:D002340

